Oric Pharmaceuticals Inc. buy BiotechBee
Start price
20.01.23
/
50%
€6.20
Target price
30.04.25
€8.00
Performance (%)
-27.74%
End price
05.05.23
€4.48
Summary
This prediction ended on 05.05.23 with a price of €4.48. The prediction for Oric Pharmaceuticals Inc. disappointed with a performance of -27.74%. BiotechBee has a follow-up prediction for Oric Pharmaceuticals Inc. where he still thinks Oric Pharmaceuticals Inc. is a Buy. BiotechBee has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Oric Pharmaceuticals Inc. | - | - | - |
| iShares Core DAX® | 1.051% | -1.833% | 12.822% |
| iShares Nasdaq 100 | -0.547% | -3.738% | 40.625% |
| iShares Nikkei 225® | -1.778% | -8.115% | 16.092% |
| iShares S&P 500 | 0.002% | -2.226% | 28.387% |
According to BiotechBee what are the pros and cons of Oric Pharmaceuticals Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Oric Pharmaceuticals Inc. diskutieren
In the thread Trading Oric Pharmaceuticals Inc.
Current prediction by BiotechBee for Oric Pharmaceuticals Inc.
Oric Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€7.70
26.06.23
26.06.23
€9.00
31.12.25
31.12.25
21.43%
11.04.24
11.04.24
Could be very worthwhile Investment >20% year
